glp-1 news today 2025 A network meta-analysis backed weight-loss benefits with several receptor agonists, with less certainty for newer-generation agents. Read more at the link in bio A network meta-analysis backed weight-loss
Description
Pfizers dose-optimization studies of once-daily formulations of danuglipron ( NCT06567327 and NCT06568731 ) met key pharmacokinetic objectives and confirmed a formulation and dose with the potential to deliver a competitive efficacy and tolerability profile in Phase 3 testing, based on earlier studies of twice-daily danuglipron
GLP-1 patches contain no GLP-1 drugs
The recent uptick and rise in popularity of GLP-1 drugs for addressing weight loss and obesity has led to an increase in U.S
Given that there are now GLP-1 pills, I'm wondering if the adoption curve will change
Similar to other diabetes drugs, metformin and Ozempic are used for managing blood sugar levels
